| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Ho William Tai-Wei | PRESIDENT AND CEO, Director, 10%+ Owner | C/O IN8BIO, INC., 350 5TH AVE. SUITE 5330, NEW YORK | /s/ William Ho | 23 Dec 2025 | 0001830914 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INAB | Common Stock | Award | $50,000 | +36,232 | +43% | $1.38 | 121,168 | 22 Dec 2025 | Direct | F1 |
| holding | INAB | Common Stock | 2,433 | 22 Dec 2025 | By child | F1 | |||||
| holding | INAB | Common Stock | 2,433 | 22 Dec 2025 | By child | F1 | |||||
| holding | INAB | Common Stock | 1,216 | 22 Dec 2025 | See footnote | F1, F2 | |||||
| holding | INAB | Common Stock | 1,216 | 22 Dec 2025 | See footnote | F1, F2 | |||||
| holding | INAB | Common Stock | 1,216 | 22 Dec 2025 | See footnote | F1, F2 |
| Id | Content |
|---|---|
| F1 | Effective June 3, 2025, the Issuer effected a 1-for-30 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. |
| F2 | The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy. |